lbt- another adelaide based bio tech company are much the same as MX1. their market cap is 20% of mx1 though.
have taken too long to get their product to turn a profit. both have a lot of potential and ceo for both has promised the wait will be worth it.
both get a bit of momentum then have long periods of quiet where the share price falls back
both companies now need sales and only sales to get the price up.
Ann: MX1 - Appendix 4D and Half Yearly Report, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
